Allmed Medical Products Co Ltd Class A (002950) — Capital Reinvestment Ratio

Latest as of September 2025: 0.37x

Allmed Medical Products Co Ltd Class A (002950) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥206.33 Million) in capital expenditures (CN¥75.70 Million). See 002950 equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.37x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥206.33 Million
CNY

Capital Expenditures

CN¥75.70 Million
CNY

Data as of

Sep 2025
Most recent filing

Allmed Medical Products Co Ltd Class A Capital Reinvestment Ratio (2014–2025)

This chart tracks Allmed Medical Products Co Ltd Class A's Capital Reinvestment Ratio across 12 annual periods. Check Allmed Medical Products Co Ltd Class A total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Allmed Medical Products Co Ltd Class A (2014–2025)

Year-by-year Capital Reinvestment Ratio for Allmed Medical Products Co Ltd Class A from 2014 to 2025. For live market cap and broader valuation context, see Allmed Medical Products Co Ltd Class A market cap and net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.36x CN¥717.13 Million CN¥260.32 Million ▲ +64.5%
2024 0.22x CN¥711.64 Million CN¥157.00 Million ▼ -67.4%
2023 0.68x CN¥423.50 Million CN¥286.48 Million ▲ +95.4%
2022 0.35x CN¥1.15 Billion CN¥398.05 Million ▼ -55.4%
2021 0.78x CN¥374.85 Million CN¥290.70 Million ▲ +358.0%
2020 0.17x CN¥1.44 Billion CN¥243.28 Million ▼ -80.1%
2019 0.85x CN¥273.13 Million CN¥232.55 Million ▼ -99.1%
2018 95.41x CN¥3.01 Million CN¥287.07 Million ▲ +4540.8%
2017 2.06x CN¥197.25 Million CN¥405.55 Million ▲ +505.7%
2016 0.34x CN¥472.74 Million CN¥160.47 Million ▼ -26.1%
2015 0.46x CN¥217.68 Million CN¥99.92 Million ▲ +43.0%
2014 0.32x CN¥293.45 Million CN¥94.19 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow